RMR vs. AMEH, ICFI, ASTH, MEG, HURN, HCKT, BWMN, III, JUNE, and LICN
Should you be buying The RMR Group stock or one of its competitors? The main competitors of The RMR Group include Apollo Medical (AMEH), ICF International (ICFI), Astrana Health (ASTH), Montrose Environmental Group (MEG), Huron Consulting Group (HURN), The Hackett Group (HCKT), Bowman Consulting Group (BWMN), Information Services Group (III), Junee (JUNE), and Lichen China (LICN). These companies are all part of the "management consulting services" industry.
Apollo Medical (NASDAQ:AMEH) and The RMR Group (NASDAQ:RMR) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, community ranking, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.
The RMR Group has lower revenue, but higher earnings than Apollo Medical. The RMR Group is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.
The RMR Group has a net margin of 4.59% compared to The RMR Group's net margin of 3.56%. The RMR Group's return on equity of 9.90% beat Apollo Medical's return on equity.
Apollo Medical has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500. Comparatively, The RMR Group has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500.
In the previous week, Apollo Medical and Apollo Medical both had 3 articles in the media. The RMR Group's average media sentiment score of 0.88 beat Apollo Medical's score of 0.46 indicating that Apollo Medical is being referred to more favorably in the media.
Apollo Medical presently has a consensus target price of $47.20, suggesting a potential upside of 15.63%. The RMR Group has a consensus target price of $32.00, suggesting a potential upside of 36.00%. Given Apollo Medical's higher possible upside, analysts clearly believe The RMR Group is more favorable than Apollo Medical.
The RMR Group received 211 more outperform votes than Apollo Medical when rated by MarketBeat users. However, 60.79% of users gave Apollo Medical an outperform vote while only 60.38% of users gave The RMR Group an outperform vote.
35.9% of Apollo Medical shares are owned by institutional investors. Comparatively, 42.3% of The RMR Group shares are owned by institutional investors. 8.5% of Apollo Medical shares are owned by company insiders. Comparatively, 54.9% of The RMR Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Apollo Medical beats The RMR Group on 9 of the 17 factors compared between the two stocks.
Get The RMR Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for RMR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RMR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The RMR Group Competitors List
Related Companies and Tools
